cls,trl_lbl,data_lvl,trials,n,m,s,q05,q95
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,agg,252,111580,58.684332026715424,10.825039389431211,40.253612971528895,75.7368761277368
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,ipd,33,27563,57.17349258218842,11.11347076853606,36.84313725490196,74.90090127278982
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,agg,178,88302,57.80440608971362,10.410144320883441,40.34727335636382,74.3804904529082
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,ipd,20,21280,59.97658494111496,10.828218467641618,41.0733953448313,76.40925486652358
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,agg,148,44794,61.18293603540255,10.775946135174605,42.76567173075986,78.10910934346299
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,ipd,29,33277,56.7773977858267,11.354744037163634,35.21600606660718,74.60408161974294
Any,Total trials,agg,530,229115,59.00947094555912,10.704452522346754,40.861666923978,75.9332949886356
Any,Total trials,ipd,74,75850,57.918702024262565,11.235424405936893,37.053485824338836,75.29120135551173
